The Performance of the Biotech Industry: Promise Versus Reality
By:
Sign Up Now!
Already a Member? Log In
You must be logged into Bookshare to access this title.
Learn about membership options,
or view our freely available titles.
- Synopsis
- Throughout the history of biotech, expectations have been high. The promise of the industry was that the through different (and superior) technology, the process of drug R&D would be transformed, and this transformation would lead to an avalanche of new drugs, and, of course, fuel profitability. In addition, it has been widely expected and perceived that smaller biotech firms are more productive at R&D than established pharmaceutical giants. This chapter explores these assumptions, examining the performance of the biotech industry over thirty years and presenting data on financial returns, profitability, and R&D productivity. This chapter is excerpted from "Science Business: The Promise, the Reality, and the Future of Biotech."
- Copyright:
- 2006
Book Details
- Book Quality:
- Publisher Quality
- Publisher:
- Harvard Business Publishing
- Date of Addition:
- 08/02/16
- Copyrighted By:
- HBS Press
- Adult content:
- No
- Language:
- English
- Has Image Descriptions:
- No
- Categories:
- Nonfiction, Business and Finance
- Submitted By:
- Bookshare Staff
- Usage Restrictions:
- This is a copyrighted book.